ND, PhD, CEO of the Ondamed
Silvia Binder is CEO of the Ondamed Companies in New York and Germany and the Founder of The Binder Institute for Personalized Medicine in Southern Germany. She was born in Germany, and grew up in Vienna, Austria, where she earned her degree in business. Her career led her to New York in 1989 where she lived for 22-years until moving back to Germany in 2010. Her personal story with her 5-year old son fueled her passion for complimentary medicine. Silvia received her N.D. degree from the College of Naturopathy in London, U.K. followed by her Ph.D. degree in naturopathy. Silvia has been helping chronically ill patients from all around the world, she is on the Advisory Boards of the Medical Wellness Association and the Occidental Institute Research Foundation, and faculty of the American Academy of Anti-Aging Medicine. Silvia is involved with clinical studies at various university clinics, lectures around the world, and offers specialized courses on Integrative Personalized Medicine for healthcare practitioners. She is the author of several scientific publications and the book “ONDAMED A story of love, healing, and medical revolution”.
ONDAMED Inventor and Founder
Rolf Binder earned his degree in electromechanical engineering in Lahr, Germany, where he then continued to work in research and development at a German Bio-medical technology company for twelve years.
In 1993, Binder came up with a totally new approach to health and wellness with his invention ONDAMED. His goal was to create a treatment modality for the medical field which would offer a specific intervention driven by the patient’s hidden emotional information linking to physiological stress and disease.
In 1994 he founded the company, Ondamed GmbH, adding Ondamed Inc (in New York) in 2002 and, together with Silvia Binder, has grown the Ondamed companies into the leading worldwide provider of medical devices using pulsed electromagnetic stimulation. Binder continues to develop new bio-physical technologies and partnering with other leaders in the bio-medical technology field.